IRIS
DE STEFANO, ALFONSO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 518
EU - Europa 301
AS - Asia 173
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.020
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 507
IT - Italia 115
CN - Cina 93
SG - Singapore 70
NL - Olanda 60
IE - Irlanda 38
UA - Ucraina 33
FI - Finlandia 28
CI - Costa d'Avorio 27
CA - Canada 11
SE - Svezia 10
IN - India 7
CZ - Repubblica Ceca 6
BE - Belgio 4
DE - Germania 3
GB - Regno Unito 2
JP - Giappone 2
BG - Bulgaria 1
EU - Europa 1
FR - Francia 1
ID - Indonesia 1
Totale 1.020
Salva come PNG Salva come JPEG
Città #
Chandler 112
Amsterdam 58
Singapore 55
Millbury 35
Beijing 34
Princeton 29
Ashburn 27
Napoli 23
Nanjing 20
Naples 18
Santa Clara 12
Boston 11
Ottawa 11
Des Moines 9
Lentini 9
Nanchang 9
Shenyang 8
Tianjin 7
Casoria 6
Jiaxing 6
Wilmington 6
Olomouc 5
Washington 5
Indiana 4
Jacksonville 4
Milan 4
Acerra 2
Boardman 2
Courcelles 2
Edegem 2
Hicksville 2
Houston 2
Messina 2
New York 2
Norwalk 2
Pune 2
Redwood City 2
San Mateo 2
Villarosa 2
Ameno 1
Augusta 1
Cagliari 1
Camparada 1
Casalnuovo 1
Castellana Grotte 1
Changchun 1
Changsha 1
Edinburgh 1
Falls Church 1
Formia 1
Hebei 1
Jakarta 1
Kronberg 1
Kunming 1
Lawrence 1
Los Angeles 1
Montesilvano Marina 1
Mountain View 1
Munich 1
Newbury Park 1
Ogliastro Cilento 1
Orange 1
Prague 1
Redmond 1
Rome 1
San Jose 1
Sant'antonio Abate 1
Seattle 1
Secunderabad 1
Serra 1
Tokyo 1
Turin 1
Viareggio 1
Totale 587
Salva come PNG Salva come JPEG
Nome #
STATO DELL'ARTE SULLA CHEMIOTERAPIA NEL CANCRO DEL COLON 82
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: A survey of young oncologists 60
Discordance in RAS mutations between primary colon tumor and metastases: a real event or a matter of methodology? 55
Bevacizumab related arterial hypertension as a predictive marker in metastatic Colorectal Cancer (mCRC) patients 43
Bevacizumab as 4th line treatment in metastatic colorectal cancer 42
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. 42
Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment 41
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients 41
Double complete response in MCRC patient 37
Concomitant Interferon-alfa and chemotherapy in hepatitis C and colorectal cancer: a case report 37
Adjuvant treatment for locally advanced rectal cancer patients after pre-operative chemoradiotherapy: when, and for whom? 37
Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: tolerability, and prognostic factors. 36
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer 36
Role of sphingosine kinase 1 (SphK1) on cetuximab resistance in colorectal cancer models 36
Primary hepatic lymphoma in a patient with previous rectal adenocarcinoma: a case report and discussion ofetiopathogenesis and diagnostic tools 34
Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients 34
Next-generation sequencing in the genomic profiling of synchronous colonic carcinomas: comment on Li et al (2015) 33
MULTIPLE PRIMARY MALIGNANT NEOPLASM AND FAMILIAR ANAMNESIS 32
Bevacizumab-induced hypertension is a predictive marker of response and progression free survival in patients treated for metastatic colorectal cancer 30
MicroRNA profiling as predictive factor of complete pathological response to neoadjuvant chemoradiothetapy in patients with locally advanced cancer 30
Sphingosine Kinase 1 (SphK1) overespression contributes to cetuximab resistance in human colrectal cancer. 30
Correlation between bevacizumab-related hypertension and response in mCRC patients 29
FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience 27
Bevacizumab maintenance in metastatic colorectal cancer: How long? 27
Neoadjuvant treatment with capecitabine and oxaliplatin in combination with radiotherapy for rectal cancer patients: a phase II study 24
KRAS mutation detection by high resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer 24
Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer 23
SANGER SEQUENCING IN ROUTINE KRAS TESTING: AREVIEW OF 1720 CASES FROM A PATHOLOGIST’SPERSPECTIVE 22
Predictive factors of complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer 21
Surgery in lung cancer metastasis 21
Totale 1.066
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.746
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202055 0 0 0 0 3 1 0 3 0 12 27 9
2020/202167 1 3 6 5 4 14 9 4 11 2 6 2
2021/2022221 3 1 2 4 1 11 1 7 48 23 47 73
2022/2023284 31 15 9 19 29 31 0 30 45 59 13 3
2023/2024166 4 27 29 13 6 19 0 29 0 1 22 16
2024/202589 42 43 4 0 0 0 0 0 0 0 0 0
Totale 1.066